Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l -rhamnose displaying liposomes

Bioconjugate Chemistry

Volumn 24, Issue 3, 2013, Pages 363-375

  Sarkar, Sourav ^a   Salyer, Alex C D ^b   Wall, Katherine A ^b   Sucheck, Steven J ^a  

^a UNIVERSITY OF TOLEDO   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CHOLESTEROL; EPITOPES; ETHYLENE; ETHYLENE GLYCOL; IMMUNIZATION; LIPOSOMES; MAMMALS; PEPTIDES; T-CELLS;

ANTIBODY TITERS; BALB/C MICE; L-RHAMNOSE; MUC1 GLYCOPEPTIDES; RECEPTOR LIGANDS; SELF TOLERANCE; TANDEM REPEATS; TOLL-LIKE RECEPTORS; TRANSGENIC MICE; VARIABLE NUMBER;

VACCINES;

CANCER VACCINE; ETHYLENE GLYCOL DERIVATIVE; FICOLL; LIPOSOME; MUCIN 1; PAM3CYS MUC1 TN; RHA-FICOLL; RHAMNOSE; TETRAETHYLENE GLYCOL; TOLL LIKE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNIZATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG CONJUGATION; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; LIGHT SCATTERING; LIPOSOMAL DELIVERY; LYMPHOCYTE PROLIFERATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SPLEEN CELL; T LYMPHOCYTE; TREATMENT DURATION; VARIABLE NUMBER OF TANDEM REPEAT;

MUS; MUS MUSCULUS; TETRA;

EID: 84875453882     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300422a     Document Type: Article

References (49)

1. Livingston, P. O., Wong, G. Y., and Adluri, S. (1994) Improved survival in stage III melanoma patients with GM2 antibodies: A randomized trial of adjuvant vaccination with GM2 ganglioside J. Clin. Oncol. 12, 1036-1044
2. Solvin, S. F., Keding, S. J., and Raghupati, G. (2005) Carbohydrate vaccines as immunotherapy for cancer Immunol. Cell Biol. 83, 418-428
3. a vaccine Can. Immunol. Immunother. 58, 1397-1405
4. Emens, L. A., Reilly, R. T., and Jaffee, E. M. (2005) Breast cancer vaccines: Maximizing cancer treatment by tapping into host immunity Endocr.-Relat. Cancer 12, 1-17
5. Dziadek, S., Kowalczyk, D., and Kunz, H. (2005) Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and bovine serum albumin Angew. Chem., Int. Ed. 44, 7624-7630
6. Raghupati, G., Koide, F., Livingston, P. O., Cho, Y. S., Endo, A., Wan, Q., Spassove, M. K., Keding, S. J., Allen, J., Ouerfelli, O., Wilson, R. M., and Danishefsky, S. J. (2006) Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: A synthetic route to anticancer vaccine candidates J. Am. Chem. Soc. 128, 2715-2725
7. Hoffmann-Röder, A. and Johannes, M. (2011) Synthesis of a MUC1-glycopeptide-BSA conjugate vaccine bearing the 3′-deoxy-3′- fluoro-Thomsen-Friedenreich antigen Chem. Commun. 47, 9903-9905
8. Lakshminarayanana, V., Thompson, P., Wolfert, M. A., Buskas, T., Bradley, J. M., Pathangey, L. B., Madsen, C. S., Cohen, P. A., Gendler, S. J., and Boons, G.-J. (2012) Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine Proc. Natl. Acad. Sci. U.S.A. 109, 261-266
9. Patton, S., Gendler, S. J., and Spicer, A. P. (1995) The epithelial mucin, MUC1, of milk, mammary gland and other tissues Biochim. Biophys. Acta 1241, 407-423
10. Springer, G. F. (1984) T and Tn, general carcinoma autoantigens Science 224, 1198-1206
11. Hanisch, F. G., Stadie, T. R., Deutzmann, F., and Peter-Katalanic, J. (1996) MUC1 glycoforms in breast cancer. Cell line T47D as a model for carcinoma-associated alterations of O-glycosylation Eur. J. Biochem. 236, 318-327
12. Ryan, S. O., Vlad, A. M., Islam, K., Gariépy, J., and Finn, O. J. (2009) Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice Biol. Chem. 390, 611-618
13. Ryan, S. O., Turner, M. S., Gariepy, J., and Finn, O. J. (2010) Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses Cancer Res. 70, 5788-5796
14. Galili, U. and LaTemple, D. C. (1997) Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity Immunol. Today 18, 281-285
15. Abdel-Motal, U. M., Wigglesworth, K., and Galili, U. (2009) Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody Vaccine 27, 3072-3082
16. Abdel-Motal, U., Guay, H. M., Wigglesworth, K., Welsh, R. M., and Galili, U. J. (2007) Immunogenicity of influenza virus vaccine is increased by anti-Gal-mediated targeting to antigen-presenting cells J. Virol. 81, 9131-9141
17. Abdel-Motal, U., Wang, S., Lu, S., Wigglesworth, K., and Galili, U. (2006) Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galα1-3Galβ1-4GlcNAc-R epitopes J. Virol. 80, 6943-6951
18. Huflejt, M. E., Vuskovic, M., Vasiliu, D., Xu, H., Obukhova, P., Shilova, N., Tuzikov, A., Galanina, O., Arun, B., Lu, K., and Bovin, N. (2009) Anti-carbohydrate antibodies of normal sera: Findings, surprises and challenges Mol. Immunol. 46, 3037-3049
19. Oyelaran, O., McShane, L. M., Dodd, L., and Gildersleeve, J. C. (2009) Profiling human serum antibodies with a carbohydrate antigen microarray J. Proteome Res. 8, 4301-4310
20. Chen, W., Gu, L., Zhang, W., Motari, E., Cai, L., Styslinger, T. J., and Wang, P. G. (2011) l -Rhamnose antigen: A promising alternative to α-Gal for cancer immunotherapies ACS Chem. Biol. 6, 185-191
21. Sarkar, S., Lombardo, S. A., Herner, D. N., Talan, R. S., Wall, K. A., and Sucheck, S. J. (2010) Synthesis of a single-molecule l -rhamnose-containing three-component vaccine and evaluation of antigenicity in the presence of anti-l -rhamnose antibodies J. Am. Chem. Soc. 132, 17236-17246
22. Ignatitus, R., Mahnke, K., Riveria, M., Hong, K., Isdell, F., Steinman, R. M., Pope, M., and Stamatatos, L. (2000) Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo Blood 96, 3505-3513
23. Foged, C., Arigita, C., Sundblad, A., Jiskoot, W., Storm, G., and Frokjaer, S. (2004) Interaction of dendritic cells with antigen-containing liposomes: Effect of bilayer composition Vaccine 22, 1903-1913
24. Mallick, A. I., Sinha, H., Chaudhuri, P., Nadeem, A., Khan, S. A., Dar, K. A., and Owasis, M. (2007) Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection Vaccine 25, 3692-3704
25. Jéroîme, V., Graser, A., Müller, R., Kontermann, R. E., and Konur, A. (2006) Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by Lliposome-encapsulated TRP2 peptide and CpG DNA adjuvant J. Immunother. 29, 294-305
26. Arika, S. and Takeda, K. (2004) Toll-like receptor signaling Nat. Rev. Immunol. 4, 499-511
27. Armarego, W. L. C. and Christina, C. L. L. (2003) Purification of Laboratory Chemicals, 5 th ed., pp 80-388, Butterworth-Heinemann, New York.
28. Bardonnet, P.-L., Faivre, V., Pirot, F., Boullanger, P., and Falson, F. (2005) Cholesteryl oligoethyleneglycol glycosides: Fluidizing effect of their embedment into phospholipid bilayers Biochem. Biophys. Res. Commun. 329, 1186-1192
29. Masuda, T., Akita, H., Niikura, K., Nishio, T., Ukawa, M., Enoto, K., Danev, R., Nagayama, K., Ijiro, K., and Harashima, H. (2009) Envelope-type lipid nanoparticles incorporating a short PEG-lipid conjugate for improved control of intracellular trafficking and transgene transcription Biomaterials 30, 4806-4814
30. Zeng, W., Ghosh, S., Lau, Y. F., Brown, L. E., and Jackson, D. C. (2002) Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines J. Immunol. 169, 4905-4912
31. Buskas, T., Ingale, S., and Boons, G.-J. (2005) Towards a fully synthetic carbohydrate-based anticancer vaccine: Synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated Tn antigen Angew. Chem., Int. Ed. 44, 5985-5988
32. α-Fmoc protected derivatives of S -(2,3-dihydroxypropyl)- cysteine and their application in peptide synthesis Int. J. Pept. Protein Res. 38, 545-554
33. Høeg-Jensen, T., Jakobsen, M. H., and Holm, A. (1991) A new method for rapid solution synthesis of shorter peptides by use of (benzotriazolyloxy) tripyrrolidinophosphonium hexafluorophosphate (PyBOP) Tetrahedr. Lett. 32, 6387-6390
34. Pettit, G. R., Lippert, J. W., III, Taylor, S. R., Tan, R., and Williams, M. D. (2001) Synthesis of phakellistatin 11: A Micronesia (Chuuk) marine sponge cyclooctapeptide J. Nat. Prod. 64, 883-891
35. Reichel, F., Ashton, P., and Boons, G.-J. (1997) Synthetic carbohydrate-based vaccines: Synthesis of an l -glycero-D-manno-heptose antigen-T-epitope-lipopeptide conjugate Chem. Commun. 21, 2087-2088
36. Cai, H., Huang, Z.-H., Shi, L., Zhao, Y.-F., Kunz, H., and Li, Y.-M. (2011) Towards a fully synthetic MUC1-based anticancer vaccine: Efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry Chem. Eur. J. 17, 6396-6406
37. Yamada, T., Peng, C. G., Matsuda, S., Addepalli, H., Jayaprakash, K. N., Alam, M. R., Mills, K., Maier, M. A., Charisse, K., Sekine, M., Manoharan, M., and Rajeev, K. G. (2011) versatile site-specific conjugation of small molecules to siRNA using click chemistry J. Org. Chem. 76, 1198-1211
38. Oslon, F., Hunt, C. A., Szoka, F. C., Vail, W. J., and Papahadjopoulos, D. (1979) Studies on the biosynthesis of sulfolipids in the diatom Nitzschia alba Biochim. Biophys. Acta 557, 9-23
39. Brewer, J. M., Tetley, L., Richmond, J., Liew, F. Y., and Alexander, J. (1998) Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen J. Immunol. 161, 4000-4007
40. Sharon, R., McMaster, P. R. B., Kask, A. M., Owens, J. D., and Paul, W. E. (1975) DNP [2,4-dinitrophenyl]-Lys-Ficoll, a T-independent antigen which elicits both IgM and IgG anti-DNP antibody-secreting cells J. Immunol. 114, 1585-1589
41. Inman, J. K. (1975) Thymus-independent antigens. Preparation of covalent, hapten-Ficoll conjugates J. Immunol. 114, 704-709
42. Norberg, O., Deng, L., Yan, M., and Ramström, O. (2009) Photo-click immobilization of carbohydrates on polymeric surfaces-A quick method to functionalize surfaces for biomolecular recognition studies Bioconjugate Chem. 20, 2364-2370
43. Zhu, J., Zhu, X., Kang, E. T., and Neoh, K. G. (2007) Design and synthesis of star polymers with hetero-arms by the combination of controlled radical polymerizations and click chemistry Polymer 48, 6992-6999
44. Chen, L., Li, J., Luo, C., Liu, H., Xu, W., Chen, G., Liew, O. W., Zhu, W., Puah, C. M., Shen, X., and Jiang, H. (2006) Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure-activity relationship studies reveal salient pharmacophore features Bioorg. Med. Chem. 14, 8295-8306
45. Ni, J., Singh, S., and Wang, L.-X. (2003) Synthesis of maleimide-activated carbohydrates as chemoselective tags for site-specific glycosylation of peptides and proteins Bioconjugate Chem. 14, 232-238
46. Sundaram, P. V. and Venkatesh, R. (1998) Retardation of thermal and urea induced inactivation of α-chymotrypsin by modification with carbohydrate polymers Protein Eng. 11, 699-705
47. 3 Anal. Bioanal. Chem. 381, 1130-1137
48. Gavin, A., Barns, N., Dijstelbloem, H., and Hogarth, M. (1998) Identification of the mouse IgG3 receptor: Implications for antibody effector function at the interface between innate and adaptive immunity J. Immunol. 160, 20-23
49. D'Ambrosio, D., Hippenst, K. L., Minskoff, S. A., Mellman, I., Pani, G., Siminovitch, K. A., and Cambier, J. C. (1995) Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1 Science 268, 293-297